SHOX2 is reported to activate the TGF-β receptor I (TβR-I) gene through the consensus HOX-binding site in its promoter, leading to EMT induction and invasion through the TGF-β signaling network in epithelial-like breast cancer cells [8]. The gene discussed is SHOX2; the disease is breast cancer.